1-3 of 3
Kara Olson
Close
Sort by
Journal Articles

REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells

David J Dilillo, PhD, Kara Olson, MS, Katja Mohrs, T. Craig Meagher, PhD, Kevin Bray, PhD, Olga Sineshchekova, Thomas Startz, Marc Retter, PhD, Stephen Godin, PhD, Frank Delfino, PhD, John Lin, PhD, Eric Smith, PhD, Olin Gavin Thurston, PhD, Jessica R. Kirshner, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1944.
https://doi.org/10.1182/blood-2018-99-112500
Published: 2018
Journal Articles

CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Activity Against CD20-Expressing Tumors in Immune Competent Mice Humanized for CD20 and CD3

Bindu Varghese, PhD, Jayanthi Menon, Luis Rodriguez, Kara Olson, Pamela Krueger, Tammy Huang, PhD, Eric Smith, PhD, Gavin Thurston, PhD, Jessica R. Kirshner, PhD
Journal: Blood
Blood (2015) 126 (23): 818.
https://doi.org/10.1182/blood.V126.23.818.818
Published: 2015
Journal Articles

A Novel CD20xCD3 Bispecific Fully Human Antibody Induces Potent Anti-Tumor Effects Against B Cell Lymphoma in Mice

Bindu Varghese, PhD, Jayanthi Menon, Luis Rodriguez, Lauric Haber, Kara Olson, Paurene Duramad, PhD, Adelekan Oyejide, Eric Smith, PhD, Gavin Thurston, PhD, Jessica Kirshner, PhD
Journal: Blood
Blood (2014) 124 (21): 4501.
https://doi.org/10.1182/blood.V124.21.4501.4501
Published: 2014